Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001167966-12-000088
Filing Date
2012-05-08
Accepted
2012-05-08 16:31:12
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q actc_10q-033112.htm 10-Q 942828
2 CERTIFICATION actc_10q-ex3101.htm EX-31.1 10601
3 CERTIFICATION actc_10q-ex3201.htm EX-32.1 5447
  Complete submission text file 0001167966-12-000088.txt   3908108

Data Files

Seq Description Document Type Size
4 XBRL EXHIBIT actc-20120331.xml EX-101.INS 606577
5 XBRL EXHIBIT actc-20120331.xsd EX-101.SCH 24137
6 XBRL EXHIBIT actc-20120331_cal.xml EX-101.CAL 29539
7 XBRL EXHIBIT actc-20120331_def.xml EX-101.DEF 126417
8 XBRL EXHIBIT actc-20120331_lab.xml EX-101.LAB 152578
9 XBRL EXHIBIT actc-20120331_pre.xml EX-101.PRE 129398
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
ADVANCED CELL TECHNOLOGY, INC. (Filer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50295 | Film No.: 12821811
SIC: 2834 Pharmaceutical Preparations